To improve implant biocompatibility, we developed a simple cost-effective thermal surface treatment allowing an increase in the oxide layer thickness of a titanium (Ti) alloy used in orthopaedic implants. The goal of this study was to test in vitro the reaction of osteoblasts to the developed surface treatment and to compare it to the osteoblast reaction to two other surface treatments currently used in the practice of implant surgery. Quantification of osteoblast gene expression on a large scale was used in this study. The kinetics of gene expression over 120 h was followed for 58 genes to quantify the effect of the developed surface treatment. Twenty eight genes were further selected to compare the effects of surface treatments on osteoblasts. Based on the genes studied, we could propose a general pathway for the cell reaction according to the surface treatments used: (1) metal ion release changes the time course of gene expression in the FAK pathway; (2) once the accumulation of metal ions released from the Ti surface exceeds a threshold value, cell growth is diminished and apoptosis may be activated; (3) PTK up-regulation is also induced by metal ion release; (4) the expression of Bcl-2 family and Bax may suggest that metal ions induce apoptosis. The developed treatment seems to increase the Ti-6Al-4V biocompatibility as highlighted by the lower impact of this treatment by the different pathways studied, on the lower inflammatory reaction that could be induced, as well as by the lower induced osteoblast apoptosis compared to the two other surface treatments. r
Introduction
When an implant is inserted into bone, it is expected that an apposition of bone to the implant will occur, a process called osteointegration [1] . From histological examinations it has been found that implant loosening is generally associated with the formation of fibrous tissue at the bone-implant interface [2] .
It has been hypothesized that the differentiation process of the peri-implant tissue could be driven either by unfavourable mechanical situations [3] or by inflammatory reactions following the phagocytosis of wear particles [4] or by a combination of both [5] . We recently showed that wear particles also influence osteoblast behaviour [6] [7] [8] [9] . Release of metal ions by the implant and their effect on osteoblasts has been mostly neglected until recently [10] . Due to the faster process of ion released compared to wear particles generation, interaction of osteoblast-ion would be important to quantify as this phenomenon occurs soon after prosthesis implantation.
To improve implant biocompatibility, we developed a simple, cost-effective thermal surface treatment allowing an increase in the oxide layer thickness of a titanium alloy used for orthopaedic implants [11, 12] . This oxide layer acts as a barrier to keep ions from being released into the body. Kinetic analysis showed a decrease in ion release in the developed surface treatment [13] .
Information on Ti-6Al-4V alloy treated surfaces affecting osteoblasts is limited. The goal of this study is then to test the osteoblast reaction to the developed surface treatment and to compare it to the osteoblast reaction to two other surface treatments currently used in the practice of orthopaedic implant surgery. The strategy of this study is to perform a large-scale analysis of gene expression in order to highlight possible regulation pathways differentiated by the surface treatments.
Materials and methods

Ti alloy surface preparations
Distal sections of forged Ti-6Al-4V alloy femoral stems from the Ti-Mod Freeman hip implant were supplied by Finsbury Instruments (Leatherhead, Surrey, UK). The hip stems were cut into discs of 10 mm diameter and of 1 mm thickness. The samples were polished following a previously described procedure [14] . The samples were then cleaned in 1% Triton solution for 1 h and rinsed in deionized distilled water. This treatment was used as control (C). The practice for surface preparation of surgical implants involves a nitric acid passivation treatment (P) with an immersion of the implants in 30% nitric acid for 1 h [15] . We developed a third treatment that we called aged treatment (A), which consisted of the passivated treatment followed by ageing in boiling deionized distilled water for 10 h [11, 12] . The samples were then sterilized and tested for endotoxin contamination [14] .
Cell culture
Primary human osteoblasts (hOB) were isolated from pieces of cortical bone femur obtained during total hip arthroplasty of a female patient (62 yr) following a procedure previously described [16] . The osteoblastic cells were cultured in Dulbecco's modified Eagle's medium (Sigma, Buchs, Switzerland) containing 10% fetal bovine serum (Sigma), 1% PSF (100 Â , 10,000 U/ ml Penicillin, 10,000 mg/ml Streptomycin and 25 mg/ml Fungizone) (GibcoBRL, Life Technologies, Basel, Switzerland) under a humidified 5% CO 2 /air atmosphere at 371C. Osteoblasts passages lower than 4 were used for the study. The osteoblasts were seeded at a concentration of 380,000 cells/cm 2 on each sample. In order to have enough material to study gene expression, 6 samples of each treated surface were used (total cells number: 1.62 Â 10 7 ).
Gene expression study
Genefilters GF211 (Research Genetics, Huntsville, AL, USA) were used to monitor the expression of 12,626 genes. The collected RNA from the cells (5 mg of total RNA per condition) was processed according to the manufacturer's recommendations. The Pathways t software, developed by Research Genetics was used to acquire the Genefilters data. Normalization of gene expression and data analysis was performed using Excel (Microsoft Corporation, Redmond, WA, USA) and 2HAPI, a web-based bioinformatics software (http:// array.sdsc.edu). The kinetics of gene expression for hOB incubated with the aged Ti-6Al-4V was measured at 4, 24, 48 and 120 h. The gene expression of cells incubated 4 h on the aged sample (A 4 ) was chosen as the reference. 58 genes were selected and classified in 6 groups according to adhesion, signal pathway and transcription factors, growth factors and cytokines, differentiation, mineralization and apoptosis. This selection represents a panel of major genes expressed by osteoblasts [17, 18] .
Twenty-eight genes were specifically analysed to compare the difference in gene expression between different surface treatments. The results are presented as the ratio of P/A and C/A for the corresponding gene expression.
For both analyses, the difference in gene expression is based on the experimental finding that upregulation by a ratio higher than 2.5-fold or down-regulation by a ratio lower than 0.4-fold (=1/2.5) has to be reached to be considered as significant. Sample control at 24 h was analysed twice with two filters (C 24 (1) and C 24 (2) ) and showed good reproducibility (70% of the gene tested had a gene expression variation lower than 10% between the two analysis) (data not shown).
Results
The results presented in Table 1 are intended to  evaluate the kinetics of gene modulation of the surface  treatment A, while results presented in Table 2 are used to compare gene expression with respect to the different surface treatments (C, P, A). The functional description of the chosen genes is given in Table 3 . Sample A 24 did not have enough RNA for the analysis.
3.1. Kinetics of genes modulation by the surface treatment A (Table 1) From a quantitative point of view, in comparison with A 4 , A 48 has 213 up-regulated genes and 5 downregulated genes; A 120 has 247 up-regulated genes and 5 down-regulated genes. More specifically, 58 genes were selected and described in the following groups.
Adhesion
Collagen alpha-2 type I was up regulated 4.4-fold at 48 h and 3.48-fold at 120 h compared to A 4 . Integrin a 3 ; a 5 ; a 6 ; b 1 ; b 5 ; and fibronectin were expressed by the isolated hOB, but did not show a significant difference compared to A 4 . 
Human bcl-2 mRNA (BCL2 (B-cell CLL/lymphoma 2)) --
Signal pathways and transcription factors
Focal adhesion kinase (FAK) and mitogen-activated protein (MAP) kinases were down-regulated at 48 and 120 h. c-jun showed a 0.43-fold decrease and c-fos was increased 2.23-fold for A 48 . Protein tyrosine kinase (PTK9) showed a 0.5-fold decrease at 48 h. PTK receptor was upregulated 3.20-fold at 48 h and increased with time. Stem cell tyrosine kinase 1 (STK-1) was upregulated 10.10-fold at 48 h but undetected at 120 h.
Growth factors and cytokines
FGF-5 was up-regulated 5.85-fold and increased to 6.37-fold at 120 h. Keratinocyte growth factor (KGF=FGF-7) was up-regulated 2.8-fold at 120 h. Insulin-like growth factor (IGF-1) was up-regulated 4.38-fold at 48 h and not detected at 120 h. Transforming growth-factor-b-induced gene (BIGH3) and plateletderived growth factor (PDGF-A) were detected, but did not show significant modulation. Most of the BMPs were not detected (BMP-2A, BMP-3 and BMP-5, data not shown) or down-regulated (BMP-1, BMP-2B and BMP-4). Genes, which have been proved to be involved in the process of osteoporosis, such as basic fibroblast growth factor, (FGF-2 or bFGF) and interleukin 1 alpha (IL-1a) were either absent or down-regulated compared to the reference A 4 . The expression of proinflammatory mediators including IL-6 and prostaglandin E-2 (PGE-2) were not detected (data not shown).
Differentiation
No significant gene expression for core-binding factor runt domain alpha subunit 1 (cbfa1), Indian hedgehog (IHH) and homeodomain (BAPX1) was observed, except for alkaline phosphatase (ALP), which had a 1.22-fold increase at 48 h and a 1.45-fold increase at 120 h.
Mineralization
SPARC/osteonectin, osteopontin (OPN), and biglycan (bone matrix glycoproteins), which are involved in bone matrix mineralization, were detected. SPARC had a 1.76-fold increase, OPN showed a 0.86-fold decrease and biglycan showed a 1.42-fold increase at 48 h. Sialoprotein precursor (IBSP) was absent.
Apoptosis
NF-kB1 showed a 0.85-fold decrease at 48 h and 0.92-fold decrease at 120 h. NF-kB p65 showed a 0.69-fold decrease at 48 h and a 0.83-fold decrease at 120 h. The apoptosis related protein, TFAR15, showed a 0.52-fold decrease at 48 h and a down-regulation of 0.41-fold at 120 h. Bcl-xL was up-regulated 6.42-fold at 48 h and upregulated 10.08-fold at 120 h. Bax isoform (alpha, beta, gamma and delta) decreased over time.
3.2.
Comparison of gene expression with respect to the surface treatments C, P, A (Table 2) In order to determine differential hOB gene expression from various treated surfaces, 28 genes were selected from Table 1 and described in the following groups.
Adhesion
Collagen alpha-2 type I expression increased by 1.45-and 1.18-fold for samples P 48 and C 48 compared to A 48 , and decreased by 0.70-and 0.74-fold for samples P 120 and C 120 compared to A 120 , respectively.
Signal pathways and transcription factors
FAK was up-regulated 4.25-and 6.63-fold for samples P 48 and C 48 compared to A 48 . MAPK6 was up-regulated 2.59-fold for sample C 48 compared to A 48 . c-jun increased by 1.84-fold for samples P 48 and C 48 , then decreased over time. c-fos expression was downregulated 0.27-fold for sample C 48 and increased with time for samples P and C. PTK9 was up-regulated 3.26-fold for sample C 48 compared to A 48 . Serine/threonine kinases (STK-1) did not show difference between samples. 
Growth factors and cytokines
IGF-I expression decreased by 0.58-fold for sample P 48 and increased by 1.45-fold for sample C 48 . FGF-5 decreased at 48 h and increased at 120 h for samples P and C compared to sample A. Keratinocyte growth factor (KGF=FGF7) was up-regulated 4.90-fold and 7.07-fold for samples C 48 and P 48 . FGF-2 (bFGF) was up-regulated 3.19-fold for sample C 48 and was increased 2.40-fold for P 48 .
Differentiation
ALP was not detected for samples P and C during the test.
Mineralization
SPARC/osteonectin and biglycan had a 0.95-fold decrease for samples P 48 and C 48 compared to sample A 48 . 
Apoptosis
NF-kB1 increased 1.51-and 1.31-fold for samples P 48 and C 48 , respectively, then decreased at 120 h. NF-kB p65 (Rel A) decreased with time. TFAR15 was upregulated 2.75-and 2.56-fold for samples P 48 and C 48 compared to A 48 . Bcl-xL was absent for samples P 48 and C 48 . It was down-regulated 0.14-fold for sample C 120 and decreased 0.90-fold for sample P 120 compared to A 120 . Bax isoform (alpha, beta, and delta) increased with time and also increased for samples P 120 and C 120 compared to A 120 .
Discussion
cDNA microarray technology was used to obtain a high-throughput of information on osteoblasts reaction to different titanium surface treatments. In order to have confidence in the results, we have performed the analysis of one sample (C 24 ) twice with two Genefilters. Although not identical, a comparison of results showed a good agreement of the gene expression values between the two filters.
It has been shown that surface roughness influenced the cell behaviour [19] . We have used XPS and AFM techniques to examine the surface properties of the treated Ti-6Al-4V surfaces [20] . A difference in roughness (R a ) between the passivated and the aged samples could only be observed at a small scale (1 mm 2 ). The area average R a was about 0.99 nm (C), 1.29 nm (P) and 0.56 nm (A). Therefore, at the cell level, the roughness could be considered as similar between samples and could not explain the differences in osteoblasts behaviour. These differences are then Induces apoptosis NF-kB1 NFKB1 P105 is the precursor of the p50 subunit of the nuclear factor NF-kappa-b, which binds to the kappa-b consensus sequence 5 0 -ggrnnyycc-3 0 , located in the enhancer region of genes involved in immune response and acute phase reactions. The precursor protein itself does not bind to DNA NF-kB p65 RELA p65 is a subunit of the nuclear factor kappa-b, a second messenger, which activates the transcription of a number of genes in multiple tissues. The inhibitory effect of i-kappa-b upon NF-kappa-b in the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-b complex OPG TNFSF11 Tumour necrosis factor superfamily, member 11 TNFRSF11A (RANK) and OPG (osteprogerin ligand), localized in T cells bone marrow stromal cells, hypertrophic chondrocyte, stimulated by IL1B and TNFRSF11B,expressed in bone, brain, heart, kidney, skeletal muscle, skin, cooperating with prostaglandin, mediating osteoclastognesis and bone loss through systemic activation of T cells, regulating lymph node organogenesis lymphocyte development and interactions between T cells and dendritic cells, activating the antiapoptotic serine threonine kinase AKT/PKB through a signal complex involving TRAF6 and SRC  RANK  TNFRSF11A  TRANCE  TNFSF11  TFAK15 PDCD10 -CSFs CSF1 Granulocyte/macrophage colony-stimulating factors are cytokines that act in hematopoiesis by controlling the production, differentiation, and function of two related white cell populations of the blood, the granulocytes and the monocytes-macrophages It has been demonstrated that osteoblasts cultured on Ti-6Al-4V produce FAK and MAPK within 24 h [22] . According to our results, down-regulation of FAK and MAPK at 48 h would not contradict the Pathway 1, especially if integrins were not modulated which was the case at 48 h. c-jun expression of osteoblasts cultured on Ti-6Al-4V was also shown to be expressed before c-fos [22] . In our experiment, we noted a down-regulation of c-jun and an up-regulation of c-fos at 48 h, which is then in accordance with the time course of events for c-jun and c-fos expression. It is then reasonable to admit that the osteoblast interaction with the surface treatment A followed the Pathway 1. The expression of PTK decreased over time. Indeed, PTK has been showed to follow the Pathway 2 in macrophages when metal particles were present [23] Surface membrane receptors binding particles -PTK and Serine=Threonine kinase -NF-kB-Releasing TNF=IL-6 ðPathway 2Þ:
The osteoblasts also possess an inflammatory signaling response similar to Pathway 2 [24] . Following the decrease of PTK, we did not observe any modulation of NF-kB or IL-6. It is possible that either the concentration of metal ions released from the aged sample is unable to stimulate the PTK pathway in osteoblasts or the induced signal pathway is different between particles and ions. Several genes involved in the apoptosis process [25] [26] [27] such as TRAIL, TRAIL-R3, RANK, TRANCE, CSFs were not detected while NF-kB1, NF-kB p65, TFAR15 had their expression decreased. In addition, the up-regulation of Bcl-xL, which is an inhibitor of apoptosis [28] , increased with time. Conversely, the expression of Bax, which can accelerate apoptosis [28] , decreased with time. These results could indicate that the surface treatment A did not stimulate the activation of apoptosis at 120 h. Therefore the survival of osteoblasts could be enhanced on the aged surface treatment. However, these results need to be confirmed by direct apoptosis measurement such as TUNEL assay.
Without the expression of NF-kB, or CSFs, osteoblasts are unable to secrete cytokines such as IL-1 or IL-6 involved in the differentiation and apoptosis of osteoclasts [25, 26, 29] . This confirms the observation of IL-1 or IL-6 expressions not being detected in our experiment. Based on the genes studied in this experiment, no stimulating effect of osteoblasts on osteoclasts differentiation or activation through cytokine expression seems to be involved in the 120 h of this experiment.
4.2.
Comparison of gene expression with respect to the surface treatments C, P, A Considering the genes involved in signal transduction, FAK was up-regulated 4.25-fold for sample P 48 and 6.63-fold for sample C 48 while MAPK6 was upregulated 2.59-fold for sample C 48 compared to A 48 . For samples P 48 and C 48 c-jun increased and c-fos decreased compared to A 48 . In addition, c-jun decreased with time while c-fos increased in all samples. All these modulations seem to indicate that samples P and C delay the time course of gene expression in the Pathway 1 compared to the sample A. By extrapolating the time course of gene expression in the Pathway 1, there should be a decrease of cell proliferation for the samples C and P compared to A. This is what we found in a previous study [14] , however using a different cell line rendering direct comparison delicate. This delay in the gene expression time course could be due to the decrease of aluminium ions being released by the surface treatment A [12] as it has been suggested that aluminium may alter the timing/regulation of the proliferation/differentiation transition point [30] .
The expression of PTK9 was differentially modulated according to the surface treatments with an up-regulation for C 48 and P 48 compared to A 48 . In our previous work [11] , we showed that the surface treatment C releases the highest amount of metal ions followed by the surface treatment P then the surface treatment A. Lending evidence that the up-regulation of PTK followed exactly the same classification. The up-regulation of PTK was then directly related to the amount of ions released. According to the Pathway 2, the surface treatment A would then be more favourable by inducing less inflammatory reaction than the surface treatment P or C.
Recently, it has been demonstrated that Ti particles induce osteoblast apoptosis [6] . Despite osteoblast reaction to particles and ions may be different, we investigated the possibility of apoptosis induced also by ions. In the present study, no modulation of Bcl-xL was detected for samples P 48 and C 48 compared to A 48 , while it was down-regulated for P 120 and C 120 compared to A 120 . On the other hand, the gene expression of Bax isoform (alpha, beta, and delta) increased with time. Osteoblast apoptosis could then be initiated from the high ratio of Bax to Bcl-xL. Based on these observations, osteoblasts may undergo more apoptosis on the surface treatment P and the C at 120 h than on the surface treatment A as a result of increased apoptotic factors expression.
Based on the genes selected in this study, we propose a general pathway of cell reaction according to the surface treatments used: 
Conclusions
The significant gene expression of collagen, FAK, MAPK, FGF-5, IGF-I and Bcl-xL demonstrated that primary human osteoblastic cells were active on the aged Ti-6Al-4V implants.
Although several apoptotic genes were expressed during the test, none of them continuously increased with time, except Bax, which suggests that Bax plays a significant role in the effects of metal ions on apoptosis.
Considering the experimental design, it has been found that most of the significant modulation took place before 48 h. Therefore, to determine the critical point of gene expression in the different pathways future genomic biocompatibility testing should be performed before 48 h following cell seeding.
Finally, the developed surface treatment A seems to increase Ti-6Al-4V biocompatibility. This is highlighted by the lower impact of this treatment on the different pathways studied, by the lower inflammatory reaction, as well as by the lower induced osteoblast apoptosis compared to the surface treatment C and P.
